CA2856665C - Isolated stereoisomeric forms of (s)2-n(3-o-(propan 2-ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide - Google Patents
Isolated stereoisomeric forms of (s)2-n(3-o-(propan 2-ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide Download PDFInfo
- Publication number
- CA2856665C CA2856665C CA2856665A CA2856665A CA2856665C CA 2856665 C CA2856665 C CA 2856665C CA 2856665 A CA2856665 A CA 2856665A CA 2856665 A CA2856665 A CA 2856665A CA 2856665 C CA2856665 C CA 2856665C
- Authority
- CA
- Canada
- Prior art keywords
- pain
- compound
- treatment
- hours
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161568219P | 2011-12-08 | 2011-12-08 | |
| US61/568,219 | 2011-12-08 | ||
| PCT/IL2012/050512 WO2013084238A1 (en) | 2011-12-08 | 2012-12-06 | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2856665A1 CA2856665A1 (en) | 2013-06-13 |
| CA2856665C true CA2856665C (en) | 2019-11-12 |
Family
ID=48573665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2856665A Active CA2856665C (en) | 2011-12-08 | 2012-12-06 | Isolated stereoisomeric forms of (s)2-n(3-o-(propan 2-ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9381173B2 (https=) |
| EP (1) | EP2788317B1 (https=) |
| JP (2) | JP6411893B2 (https=) |
| CN (1) | CN103998420B (https=) |
| AU (1) | AU2012348529B2 (https=) |
| CA (1) | CA2856665C (https=) |
| DK (1) | DK2788317T3 (https=) |
| ES (1) | ES2763946T3 (https=) |
| HU (1) | HUE048570T2 (https=) |
| IN (1) | IN2014MN00919A (https=) |
| WO (1) | WO2013084238A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015173813A1 (en) * | 2014-05-14 | 2015-11-19 | Novaremed Ltd. | Pharmaceutical composition comprising stereoisomers of n-(1-(4-hydroxyphenyl)-3-(2-hydroxypropoxy)propan-2-yl)-3-phenylpropanamide for the prevention and treatment of type ii diabetes |
| KR102062268B1 (ko) | 2018-05-18 | 2020-01-03 | 한국교통대학교 산학협력단 | 발광 특성 또는 전하 전달 특성이 우수한 아지드계 가교제 |
| CN113329746B (zh) * | 2019-01-23 | 2025-05-02 | 诺瓦麦有限公司 | 用于治疗或预防疼痛、炎症和/或自身免疫的化合物 |
| EP3939578A1 (en) | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
| WO2026037478A1 (en) | 2023-08-11 | 2026-02-19 | Novaremed AG | (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1546088B1 (en) | 2002-10-03 | 2014-12-17 | Novaremed Ltd. | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| JP4939396B2 (ja) | 2004-03-26 | 2012-05-23 | ノヴァレメッド リミテッド | Ａｉｄｓ及び他のウイルス性疾患及びｈｉｖ関連感染症の改善又はその治療用化合物及びそのような化合物を含む組成物、そのような疾患及び感染症の治療方法及びそのような化合物及び組成物の製造方法 |
| US20090197781A1 (en) | 2008-01-31 | 2009-08-06 | Hari Babu Sunkara | Wellbore Fluids Comprising Poly(trimethylene ether) glycol Polymers |
| GB0804213D0 (en) * | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| US8802734B2 (en) * | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| EP2475361B1 (en) | 2009-09-09 | 2019-11-06 | Novaremed Ltd. | N-substituted benzenepropanamides for use in the treatment of pain and inflammation |
| GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
-
2012
- 2012-12-06 DK DK12855522.4T patent/DK2788317T3/da active
- 2012-12-06 ES ES12855522T patent/ES2763946T3/es active Active
- 2012-12-06 EP EP12855522.4A patent/EP2788317B1/en active Active
- 2012-12-06 CN CN201280060570.9A patent/CN103998420B/zh active Active
- 2012-12-06 CA CA2856665A patent/CA2856665C/en active Active
- 2012-12-06 AU AU2012348529A patent/AU2012348529B2/en active Active
- 2012-12-06 WO PCT/IL2012/050512 patent/WO2013084238A1/en not_active Ceased
- 2012-12-06 HU HUE12855522A patent/HUE048570T2/hu unknown
- 2012-12-06 JP JP2014545450A patent/JP6411893B2/ja active Active
-
2014
- 2014-05-16 IN IN919MUN2014 patent/IN2014MN00919A/en unknown
- 2014-05-30 US US14/291,901 patent/US9381173B2/en active Active
-
2017
- 2017-07-21 JP JP2017142137A patent/JP2018021023A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012348529B2 (en) | 2017-03-30 |
| HK1201059A1 (en) | 2015-08-21 |
| EP2788317B1 (en) | 2019-10-02 |
| WO2013084238A1 (en) | 2013-06-13 |
| DK2788317T3 (da) | 2020-01-20 |
| JP2015500831A (ja) | 2015-01-08 |
| EP2788317A4 (en) | 2015-07-08 |
| US9381173B2 (en) | 2016-07-05 |
| IN2014MN00919A (https=) | 2015-04-17 |
| CA2856665A1 (en) | 2013-06-13 |
| CN103998420A (zh) | 2014-08-20 |
| US20140275270A1 (en) | 2014-09-18 |
| JP2018021023A (ja) | 2018-02-08 |
| ES2763946T3 (es) | 2020-06-01 |
| AU2012348529A1 (en) | 2014-06-12 |
| JP6411893B2 (ja) | 2018-10-31 |
| CN103998420B (zh) | 2018-04-17 |
| HUE048570T2 (hu) | 2020-08-28 |
| EP2788317A1 (en) | 2014-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0934061B3 (en) | Isobutylgaba and its derivatives for the treatment of pain | |
| Leggio et al. | Effectiveness and safety of baclofen in the treatment of alcohol dependent patients | |
| CA2856665C (en) | Isolated stereoisomeric forms of (s)2-n(3-o-(propan 2-ol)-1-propyl-4-hydroxybenzene)-3-phenylpropylamide | |
| Zorowitz et al. | Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP) | |
| DK164851B (da) | N-phenylmethylenalkadienamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme | |
| US10265304B2 (en) | Nootropic compositions for improving memory performance | |
| MXPA04007752A (es) | Terapia de combinacion para tratamiento de esquizofrenia. | |
| Johnson et al. | Effects of phencyclidine (PCP)-like drugs on turning behavior, 3H-dopamine uptake, and 3H-PCP binding | |
| AU2005223655B2 (en) | Methods for treating alcoholism | |
| HK1201059B (en) | Isolated stereoisomeric forms of (s) 2-n (3-o-(propan 2-ol) -1-propyl-4-hydroxybenzene) -3-phenylpropylamide | |
| ES2290292T3 (es) | Uso de acetil l-carnitina para la preparacion de un medicamento para la terapia preventiva contra el dolor posquirurgico. | |
| EP2545915A1 (en) | 2-amino-2-oxoethyl trans-3-[5-(6-methoxy-naphtalen-1-yl)-1,3-dioxan-2-yl]propyl-carbamate for use in the treatment of persistent cancer pain | |
| CN1196932A (zh) | (+)－o－去甲基反胺苯环醇作为止痛药的口服应用 | |
| JP2016528289A (ja) | ジエチル（２−シアノエチル）ホスホネートの医薬組成物および使用 | |
| BRPI0613281A2 (pt) | combinação terapêutica contendo um bloqueador de receptor nmda e uma substáncia analgésica e narcótica | |
| Harris | The roles of metabotropic and N-methyl-D-aspartate receptors for glutamate in the neuroprotective actions of N-acetyl-homotaurine (acamprosate) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20171102 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241126 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241126 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241126 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD Year of fee payment: 13 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251125 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251125 |